MY148457A - Combination preparations comprising slv308 and a dopamine agonist - Google Patents

Combination preparations comprising slv308 and a dopamine agonist

Info

Publication number: MY148457A
Authority: MY; Malaysia
Prior art keywords: slv308; dopamine agonist; combination preparations; acceptable salt; pharmacologically acceptable
Prior art date: 2006-06-16

Application number

MYPI20085078A

Other languages

English (en)

Inventor

Andrew C Mccreary

Gustaaf J M Van Scharrenburg

Martinus Th M Tulp

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2007-06-15

Publication date

2013-04-30

2007-06-15 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2013-04-30 Publication of MY148457A publication Critical patent/MY148457A/en

Links

239000003136 dopamine receptor stimulating agent Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 abstract 1
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
208000005793 Restless legs syndrome Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000010249 dopaminergic function Effects 0.000 abstract 1
238000011084 recovery Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MYPI20085078A 2006-06-16 2007-06-15 Combination preparations comprising slv308 and a dopamine agonist MY148457A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81405106P	2006-06-16	2006-06-16
EP06115583		2006-06-16

Publications (1)

Publication Number	Publication Date
MY148457A true MY148457A (en)	2013-04-30

Family

ID=38434785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20085078A MY148457A (en)	2006-06-16	2007-06-15	Combination preparations comprising slv308 and a dopamine agonist

Country Status (10)

Country	Link
EP (1)	EP2035002A1 (no)
JP (1)	JP2009539941A (no)
KR (1)	KR20090031908A (no)
AU (1)	AU2007259255A1 (no)
CA (1)	CA2654719A1 (no)
EA (1)	EA015073B1 (no)
IL (1)	IL195532A0 (no)
MY (1)	MY148457A (no)
NO (1)	NO20090164L (no)
WO (1)	WO2007144421A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0027020D0 (en)	2000-11-03	2000-12-20	Univ Manchester	Treatment of movement disorders
US20090247537A1 (en) *	2008-03-25	2009-10-01	William Dale Overfield	Methods for preventing or treating bruxism using dopaminergic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7596407B2 (en) *	2004-03-26	2009-09-29	Solvay Pharmaceuticals, B.V.	Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
US8691277B2 (en) *	2004-09-21	2014-04-08	Shandong Luye Pharmaceutical Co., Ltd.	Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
ATE417834T1 (de) *	2005-08-22	2009-01-15	Solvay Pharm Bv	N-oxide als prodrugs von piperazin- und piperidinderivaten

2007
- 2007-06-15 JP JP2009514809A patent/JP2009539941A/ja active Pending
- 2007-06-15 KR KR1020097001024A patent/KR20090031908A/ko not_active Withdrawn
- 2007-06-15 MY MYPI20085078A patent/MY148457A/en unknown
- 2007-06-15 WO PCT/EP2007/055955 patent/WO2007144421A1/en not_active Ceased
- 2007-06-15 EA EA200970021A patent/EA015073B1/ru not_active IP Right Cessation
- 2007-06-15 AU AU2007259255A patent/AU2007259255A1/en not_active Abandoned
- 2007-06-15 EP EP07730193A patent/EP2035002A1/en not_active Withdrawn
- 2007-06-15 CA CA002654719A patent/CA2654719A1/en not_active Abandoned
2008
- 2008-11-26 IL IL195532A patent/IL195532A0/en unknown
2009
- 2009-01-12 NO NO20090164A patent/NO20090164L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP2035002A1 (en)	2009-03-18
KR20090031908A (ko)	2009-03-30
AU2007259255A1 (en)	2007-12-21
NO20090164L (no)	2009-01-14
JP2009539941A (ja)	2009-11-19
IL195532A0 (en)	2009-09-01
CA2654719A1 (en)	2007-12-21
EA015073B1 (ru)	2011-04-29
WO2007144421A1 (en)	2007-12-21
EA200970021A1 (ru)	2009-06-30

Similar Documents

Publication	Publication Date	Title
MX2010013020A (es)	2011-03-21	Metodos y composiciones para trastornos del sueño y otros trastornos.
LU93321I2 (fr)	2017-01-30	Ibrutinib, ou un sel pharmaceutiquement acceptable de celui-ci
TWI320316B (en)	2010-02-11	Methods for inhibiting hscd activity,pyridazine derivatives and use and pharmaceutical composition thereof
IL186200A (en)	2013-09-30	Use of amylin and agonists, analogues and derivatives of amylin for the preparation of a drug for the treatment of psychiatric illness
MX2009011358A (es)	2009-11-05	Derivados de pirimidinona y metodos para su uso.
MX2009011359A (es)	2009-11-05	Derivados de pirimidinona y sus metodos de uso.
CL2007000789A1 (es)	2008-01-18	Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
IL195256A0 (en)	2009-08-03	Compositions of r(+)and s(-)pramipexole and methods of using the same
MX2010004450A (es)	2010-05-05	Derivados heterociclo biciclicos y su uso como moduladores de la actividad de gpr119.
UA97795C2 (uk)	2012-03-26	Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
MX2009011357A (es)	2009-11-05	Derivados de tetrahidropirido[4,3-d] pirimidinona y metodos de uso de los mismos.
MX2009000900A (es)	2009-06-18	Derivados de imidazolonas sustituidas, preparacion y usos.
SG150531A1 (en)	2009-03-30	Use of meloxicam for the treatment of respiratory diseases in pigs
EP1261340A4 (en)	2005-05-04	COMPOSITIONS AND METHODS FOR TREATING PARKINSON DISEASE
MY149854A (en)	2013-10-31	Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
LT2008075A (en)	2009-06-25	N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
TW200801022A (en)	2008-01-01	Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
WO2004069146A3 (en)	2006-09-28	L-dopa amide derivatives and uses thereof
MX2010006204A (es)	2011-03-16	Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
WO2007144422A3 (en)	2008-03-13	Combination preparations comprising bifeprunox and l-dopa
CL2007001517A1 (es)	2008-01-25	Compuestos derivados de carboxamida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, en terapia de trastornos gastrointestinales funcionales, sindrome del intestino irritable, cancer, parkinson, alzheimer, desordenes cardiovasculares.
EA202091356A1 (ru)	2020-12-30	A2a АНТАГОНИСТЫ КАК УСИЛИТЕЛИ КОГНИТИВНОЙ И МОТОРНОЙ ФУНКЦИЙ
WO2007133796A3 (en)	2008-02-07	Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
HRP20100373T1 (en)	2010-08-31	Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts